Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.79 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.79 |
| ▸ | HPGD | P15428 | 4/20 | 0.70 |
| ▸ | GAA | P10253 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | GLA | P06280 | 1/20 | 0.67 |
| ▸ | SIRT2 | Q8IXJ6 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5269737 | 1.00 | ALDH1A1 (0.79) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL5269218 | 1.00 | ALDH1A1 (0.79) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL4878921 | 0.88 | ALDH1A1 (1.00) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL725197 | 0.82 | ALDH1A1 (0.70) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL9228116 | 0.82 | ALDH1A1 (0.70) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL12856664 | 0.82 | ALDH1A1 (0.70) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL580157 | 0.82 | ALDH1A1 (0.73) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL579722 | 0.82 | ALDH1A1 (0.65) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL9223130 | 0.81 | ALDH1A1 (0.68) | ALDH1A1ALDH2HPGDGAAHSD17B10 | |
| SCHEMBL14852665 | 0.81 | ALDH1A1 (0.68) | ALDH1A1ALDH2HPGDGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112433445-B | Photosensitive resin composition for UV LED light source marking and dry film resist | 福斯特(安吉)新材料有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-112433445-A | Photosensitive resin composition for marking UV LED light source and dry film resist | 福斯特(安吉)新材料有限公司 | 2021-03-02 | — | — | CN | claimed |
| EP-1701932-B1 | TOLTERODINE, COMPOSITIONS AND USES THEREOF, AND PREPARATION OF THE SAME | CIPLA LTD (IN) | 2012-07-18 | — | — | EP | claimed |
| US-20110306792-A1 | PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF | 2Y-CHEM, LTD. (CN) | 2011-12-15 | — | — | US | claimed |
| CN-101087751-B | Process for preparation of 3-(2-hydroxy-5-methylphenyl)-n,n-diisopropyl-3phenylpropylamine | LEK PHARMACEUTICALS | 2011-11-02 | — | — | CN | claimed |
| WO-2010092500-A2 | A PROCESS FOR THE PREPARATION OF TOLTERODINE TARTRATE | ALEMBIC LIMITED (IN) | 2010-08-19 | — | — | WO | claimed |
| WO-2010046801-A2 | A PROCESS FOR THE PREPARATION OF TOLTERODINE TARTRATE | ALEMBIC LIMITED (IN) | 2010-04-29 | — | — | WO | claimed |
| US-7538249-B2 | Tolterodine, compositions and uses thereof, and preparation of the same | CIPLA LIMITED (IN) | 2009-05-26 | — | — | US | claimed |
| CN-101087751-A | Process for preparation of 3-(2-hydroxy-5-methylphenyl)-n,n-diisopropyl-3phenylpropylamine | LEK PHARMACEUTICALS (SI) | 2007-12-12 | — | — | CN | claimed |
| US-20070142479-A1 | Tolterodine, compositions and uses thereof, and preparation of the same | CIPLA LIMITED (IN) | 2007-06-21 | — | — | US | claimed |
| EP-1701932-A1 | TOLTERODINE, COMPOSITIONS AND USES THEREOF, AND PREPARATION OF THE SAME | Cipla Ltd. (IN) | 2006-09-20 | — | — | EP | claimed |
| EP-1419135-A4 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LAB LTD (IN) | 2006-01-11 | — | — | EP | claimed |
| EP-1584621-A1 | A process for the preparation of tolterodine and intermediates thereof | Dipharma S.p.A. (IT) | 2005-10-12 | — | — | EP | claimed |
| US-20050222437-A1 | Process for the preparation of tolterodine and intermediates thereof | DIPHARMA S.P.A. (IT) | 2005-10-06 | — | — | US | claimed |
| WO-2005061432-A1 | TOLTERODINE, COMPOSITIONS AND USES THEREOF, AND PREPARATION OF THE SAME | CIPLA LIMITED (IN) | 2005-07-07 | — | — | WO | claimed |
| CN-1571767-A | Process for the preparation of tolterodine | RANBAXY LAB LTD (IN) | 2005-01-26 | — | — | CN | claimed |
| US-20040249211-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | claimed |
| US-6822119-B1 | REACTING 3,4-DIHYDRO-6-METHYL-4-PHENYL-2H-BENZOPYRAN-2-ONE WITH DIMETHYL SULFATE USING PHASE TRANSFER CATALYST; DESTERIFICATION, REDUCTION, AMINATION, SULFONATION, DEPROTECTING, DECYCLIZATION, AND SALT FORMATION | RANBAXY LABORATORIES LIMITED (IN) | 2004-11-23 | — | — | US | claimed |
| EP-1419135-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES, LTD. (IN) | 2004-05-19 | — | — | EP | claimed |
| WO-2003014060-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2003-02-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306792-A1 | PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF | ACHE, QDPR, DDC | ALDH1A1 1592/4885ALDH2 757/4885HPGD 1582/4885 |
| US-20050222437-A1 | Process for the preparation of tolterodine and intermediates thereof | CYP2B6, UGT1A6, CYP2D6 | ALDH1A1 1277/4885ALDH2 1890/4885HPGD 1820/4885 |
| US-20040249211-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | ADRB3, ADRA1B, ADRA2B | ALDH1A1 1876/4885ALDH2 1887/4885HPGD 1531/4885 |
| US-20070142479-A1 | Tolterodine, compositions and uses thereof, and preparation of the same | ADRB3, ADRB2, ADRB1 | ALDH1A1 1558/4885ALDH2 1577/4885HPGD 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.